Ocugen Inc
Biotechnology
Healthcare
OCGN
292 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.39
52 week high
1.66
high
1.69
52 week low
0.00
low
1.39
growth
23.88 %
previous Close
1.39
P/E ratio
market cap
437 M
div yield
0
usd
Jun 2025
qoq
revenue
1.37 M
-7.29 %
net incoming
-14.74 M
3.98 %
eps
0.00 %
0.00 %
eps surprise
16.67 %
net profit margin
-1073.49 %
-37.00 %
operating incoming
-13.80 M
4.87 %
net change in cash
-10.78 M
47.93 %
cash on hand
27.01 M
-28.54 %
cost of revenue
0.00 %
top top